Literature DB >> 10880516

Hormone interactions to Leu-rich repeats in the gonadotropin receptors. I. Analysis of Leu-rich repeats of human luteinizing hormone/chorionic gonadotropin receptor and follicle-stimulating hormone receptor.

Y S Song1, I Ji, J Beauchamp, N W Isaacs, T H Ji.   

Abstract

The luteinizing hormone receptor (LHR) and follicle-stimulating hormone receptor (FSHR) have an approximately 350-amino acid-long, N-terminal extracellular exodomain. This exodomain binds hormone with high affinity and specificity and contains eight to nine putative Leu-rich repeat (LRR) sequences. LRRs are known to assume the horseshoe structure in ribonuclease inhibitors, and the inner lining of the horseshoe consists of the beta-stranded Leu/Ile-X-Leu/Ile motif. In the case of ribonuclease inhibitors, these beta strands interact with ribonuclease. However, it is unclear whether the putative LRRs of LHR and FSHR play any role in the structure and function. In this work, the beta-stranded Leu/Ile residues in all LRRs of the human LHR and FSHR were Ala-scanned and characterized. In addition, the 23 residues around LRR2 of LHR were Ala-scanned. The results show that beta-stranded Leu and Ile residues in all LRRs are important but not equally. These Leu/Ile-X-Leu/Ile motifs appear to form the hydrophobic core of the LRR loop, crucial for the LRR structure. Interestingly, the hot spots are primarily in the upstream and downstream LRRs of the LHR exodomain, whereas important LRRs spread throughout the FSHR exodomain. This may explain the distinct hormone specificity despite the structural similarity of the two receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880516     DOI: 10.1074/jbc.M003772200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin.

Authors:  Alyson E Fournier; Graham C Gould; Betty P Liu; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  Assembly and structural characterization of an authentic complex between human follicle stimulating hormone and a hormone-binding ectodomain of its receptor.

Authors:  Qing R Fan; Wayne A Hendrickson
Journal:  Mol Cell Endocrinol       Date:  2006-10-12       Impact factor: 4.102

3.  Trans-activation, cis-activation and signal selection of gonadotropin receptors.

Authors:  MyoungKun Jeoung; ChangWoo Lee; Inhae Ji; Tae H Ji
Journal:  Mol Cell Endocrinol       Date:  2006-10-19       Impact factor: 4.102

Review 4.  The luteinizing hormone receptor: insights into structure-function relationships and hormone-receptor-mediated changes in gene expression in ovarian cancer cells.

Authors:  David Puett; Krassimira Angelova; Marcelo Rocha da Costa; Susanne W Warrenfeltz; Francesca Fanelli
Journal:  Mol Cell Endocrinol       Date:  2010-05-02       Impact factor: 4.102

5.  Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors.

Authors:  S Costagliola; V Panneels; M Bonomi; J Koch; M C Many; G Smits; G Vassart
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

6.  Functional differences of invariant and highly conserved residues in the extracellular domain of the glycoprotein hormone receptors.

Authors:  Krassimira Angelova; Hugo de Jonge; Joke C M Granneman; David Puett; Jan Bogerd
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

7.  Trafficking of the follitropin receptor.

Authors:  Alfredo Ulloa-Aguirre; James A Dias; George Bousfield; Ilpo Huhtaniemi; Eric Reiter
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

Review 8.  A functional transmembrane complex: the luteinizing hormone receptor with bound ligand and G protein.

Authors:  D Puett; Y Li; G DeMars; K Angelova; F Fanelli
Journal:  Mol Cell Endocrinol       Date:  2006-10-23       Impact factor: 4.102

Review 9.  Structural aspects of luteinizing hormone receptor: information from molecular modeling and mutagenesis.

Authors:  Francesca Fanelli; David Puett
Journal:  Endocrine       Date:  2002-08       Impact factor: 3.633

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.